Assessment of Clinical Characteristics and Pharmacotherapy in Burning Mouth Syndrome Patients

ABSTRACT

Background:Burning Mouth Syndrome (BMS) is a type of persistent, debilitating orofacial discomfort that is characterized by an oral mucosal burning sensation that does not occur in the presence of any specific oral disease. Aim of this study was to evaluate the clinical features and medication for burning mouth condition. Materials and Methods:We examined the DIAS case file from June 2022 to March 2023, during which 50 samples were identified. Data were gathered using a specific table designed for data collection and a customized examination form. Chi square test and descriptive statistics were used to analyse the data. p>0.05, statistically significant. Results: From the study, around (38.8%) of the participants who had burning mouth syndrome are due to anxiety followed by dryness and irritation (22.2%). Current research shows that around 78% of the participants are female. Majority of the females had anxiety as the main etiological factor compared to males. Pearson chi square-10.68, p>0.016, statistically significant. Majority of the patients used Benzydamine HCl as the topical application (66%) for BMS. Conclusion:Current study proves that, majority of the burning mouth syndrome patients are females and the most common etiological factor has been found to be anxiety. Better management can be provided to patients only when the etiology is understood properly and diagnosed in a right way.

KEYWORDS

• Burning mouth syndrome
• Pharmacotherapy
• Anxiety
• Women

Showing references and in-text citations exactly as published.

• DOI10.5530/jyp.2023.15.100Copy

RELATED ARTICLES

Matched on section and article type within this issue of JYP.

• Article · VOLUME 15, ISSUE 4Mechanistic Insights into Ipriflavone's Role in Postmenopausal Osteoporosis through Integrated Computational and in vitro TechniquesAnish John, Harsha Ashtekar, Dheeraj Gupta, Pankaj Kumar, Anoop Narayanan V · pp. 629–637Original ArtcileSame type: Article
• Article · VOLUME 15, ISSUE 4Synthetic Identification of New Compounds with Anti-fungal Properties of “1-[3-(2-Hydroxyphenyl)-3-Oxop ropanoyl]- 5,5-Diphenylimidazolidine -2,4-Dione and its Derivatives”Rohit Jaysing Bhor, Shabnam Babu Shaikh, Shirole Rahul Bapusaheb, Satpute Pankaj Bhausaheb, Mahesh Hari Kolhe · pp. 638–648Original ArtcileSame type: Article
• Article · VOLUME 15, ISSUE 4Inhibitory Effects of Lawsone Methyl Ether and Lawsone and their Synergistic Interactions with Acarbose against α-Glucosidase: In silico and in vitro StudiesMuhammad Khan, Muhammad Ajmal Shah, Shabana Bibi, Pharkphoom Panichayupakaranant · pp. 649–658Original ArtcileSame type: Article
• Article · VOLUME 15, ISSUE 4Bioactive Compounds from Momordica charantia, Nigella sativa, and Anethum graveolens against Metabolic Syndrome: Untangling the Complex RelationshipRajashekar S Chavan, Nayeem A. Khatib, Vishal S. Patil · pp. 659–670Original ArtcileSame type: Article